This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Luu-The, V. Articles by Labrie, F. Search for Related Content PubMed PubMed Citation Articles by Luu-The, V. Articles by Labrie, F.

Characterization of Type 12 17ß-Hydroxysteroid Dehydrogenase, an Isoform of Type 3 17ß-Hydroxysteroid Dehydrogenase Responsible for Estradiol Formation in Women

Oncology and Molecular Endocrinology Research Center, Laval University Medical Center (CHUL) and Laval University, Quebec, Canada G1V 4G2

Address all correspondence and requests for reprints to: Professor Van Luu-The, Oncology and Molecular Endocrinology Research Center, Laval University Medical Center (Centre Hospitalier Universitaire Laval), 2705 Laurier Boulevard, Quebec, Quebec, Canada G1V 4G2.

A novel 17ß-hydroxysteroid dehydrogenase (17ß-HSD) chronologically named type 12 17ß-HSD (17ß-HSD12), that transforms estrone (E1) into estradiol (E2) was identified by sequence similarity with type 3 17ß-HSD (17ß-HSD3) that catalyzes the formation of testosterone from androstenedione in the testis. Both are encoded by large genes spanning 11 exons, most of them showing identical size. Using human embryonic kidney-293 cells stably expressing 17ß-HSD12, we have found that the enzyme catalyzes selectively and efficiently the transformation of E1 into E2, thus identifying its role in estrogen formation, in contrast with 17ß-HSD3, the enzyme involved in the biosynthesis of the androgen testosterone in the testis. Using real-time PCR to quantify mRNA in a series of human tissues, the expression levels of 17ß-HSD12 as well as two other enzymes that perform the same transformation of E1 into E2, namely type 1 17ß-HSD and type 7 17ß-HSD, it was found that 17ß-HSD12 mRNA is the most highly expressed in the ovary and mammary gland. To obtain a better understanding of the structural basis of the difference in substrate specificity between 17ß-HSD3 and 17ß-HSD12, we have performed tridimensional structure modelization using the coordinates of type 1 17ß-HSD and site-directed mutagenesis. The results show the potential role of bulky amino acid F234 in 17ß-HSD12 that blocks the entrance of androstenedione. Overall, our results strongly suggest that 17ß-HSD12 is the major estrogenic 17ß-HSD responsible for the conversion of E1 to E2 in women, especially in the ovary, the predominant source of estrogens before menopause.

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα  |  ERβ

Ligands:   17β-Estradiol  |  Dihydrotestosterone

This article has been cited by other articles:

				A. Jansson, L. Delander, C. Gunnarsson, T. Fornander, L. Skoog, B. Nordenskjold, and O. Stal Ratio of 17HSD1 to 17HSD2 Protein Expression Predicts the Outcome of Tamoxifen Treatment in Postmenopausal Breast Cancer Patients Clin. Cancer Res., May 15, 2009; 15(10): 3610 - 3616. [Abstract] [Full Text] [PDF]

				B. Delvoux, P. Groothuis, T. D'Hooghe, C. Kyama, G. Dunselman, and A. Romano Increased Production of 17{beta}-Estradiol in Endometriosis Lesions Is the Result of Impaired Metabolism J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 876 - 883. [Abstract] [Full Text] [PDF]

				S. Nagasaki, T. Suzuki, Y. Miki, J.-i. Akahira, K. Kitada, T. Ishida, H. Handa, N. Ohuchi, and H. Sasano 17{beta}-Hydroxysteroid Dehydrogenase Type 12 in Human Breast Carcinoma: A Prognostic Factor via Potential Regulation of Fatty Acid Synthesis Cancer Res., February 15, 2009; 69(4): 1392 - 1399. [Abstract] [Full Text] [PDF]

				J. M Day, H. J Tutill, A. Purohit, and M. J Reed Design and validation of specific inhibitors of 17{beta}-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis Endocr. Relat. Cancer, September 1, 2008; 15(3): 665 - 692. [Abstract] [Full Text] [PDF]

				S. Desnoyers, P.-G. Blanchard, J.-F. St-Laurent, S. N Gagnon, D. L Baillie, and V. Luu-The Caenorhabditis elegans LET-767 is able to metabolize androgens and estrogens and likely shares common ancestor with human types 3 and 12 17{beta}-hydroxysteroid dehydrogenases J. Endocrinol., November 1, 2007; 195(2): 271 - 279. [Abstract] [Full Text] [PDF]

				P.-G. Blanchard and V. Luu-The Differential androgen and estrogen substrates specificity in the mouse and primates type 12 17{beta}-hydroxysteroid dehydrogenase J. Endocrinol., August 1, 2007; 194(2): 449 - 455. [Abstract] [Full Text] [PDF]

				S. Rice and S. A Whitehead Phytoestrogens and breast cancer -promoters or protectors? Endocr. Relat. Cancer, December 1, 2006; 13(4): 995 - 1015. [Abstract] [Full Text] [PDF]

				A. K. Jansson, C. Gunnarsson, M. Cohen, T. Sivik, and O. Stal 17{beta}-Hydroxysteroid Dehydrogenase 14 Affects Estradiol Levels in Breast Cancer Cells and Is a Prognostic Marker in Estrogen Receptor-Positive Breast Cancer Cancer Res., December 1, 2006; 66(23): 11471 - 11477. [Abstract] [Full Text] [PDF]

				A Jansson, C Gunnarsson, and O Stal Proliferative responses to altered 17{beta}-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors. Endocr. Relat. Cancer, September 1, 2006; 13(3): 875 - 884. [Abstract] [Full Text] [PDF]

				Y. Takase, M.-H. Levesque, V. Luu-The, M. El-Alfy, F. Labrie, and G. Pelletier Expression of Enzymes Involved in Estrogen Metabolism in Human Prostate J. Histochem. Cytochem., August 1, 2006; 54(8): 911 - 921. [Abstract] [Full Text] [PDF]